Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 279

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

In silico clinical trials: concepts and early adoptions

Pappalardo, Francesco, Russo, Giulia, Tshinanu, Flora Musuamba, Viceconti, Marco·2019·Briefings in Bioinformatics

Abstract

Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is historically slow in adopting technological innovation, compared with other industrial sectors. In recent years, new approaches in modelling and simulation have started to provide important insights in biomedicine, opening the way for their potential use in the reduction, refinement and partial substitution of both animal and human experimentation. In light of this evidence, the European Parliament and the United States Congress made similar recommendations to their respective regulators to allow wider use of modelling and simulation within the regulatory process. In the context of in silico medicine, the term ‘in silico clinical trials’ refers to the development of patient-specific models to form virtual cohorts for testing the safety and/or efficacy of new drugs and of new medical devices. Moreover, it could be envisaged that a virtual set of patients could complement a clinical trial (reducing the number of enrolled patients and improving statistical significance), and/or advise clinical decisions. This article will review the current state of in silico clinical trials and outline directions for a full-scale adoption of patient-specific modelling and simulation in the regulatory evaluation of biomedical products. In particular, we will focus on the development of vaccine therapies, which represents, in our opinion, an ideal target for this innovative approach.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bib/bby043

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Research works printed but not linked: 15

  1. Silverman, 1961, Application of analogue computer to measurement of intestinal absorption rates with tracers, J Appl Physiol, 16, 911, 10.1152/jappl.1961.16.5.911 · doi:10.1152/jappl.1961.16.5.911
  2. Nichol, 1977, Pharmacokinetics: selectivity of action related to physicochemical properties and kinetic patterns of anticancer drugs, Cancer, 40, 519, 10.1002/1097-0142(197707)40:1+<519::AID-CNCR2820400718>3.0.CO;2-4 · doi:10.1002/1097-0142(197707)40:1+<519::aid-cncr2820400718>3.0.co;2-4
  3. Cogan, 1984, Regulation of proximal bicarbonate reabsorption, Am J Physiol, 247, F387
  4. Byczkowski, 1994, Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model, Toxicol Appl Pharmacol, 125, 228, 10.1006/taap.1994.1068 · doi:10.1006/taap.1994.1068
  5. Bassingthwaighte, 1997, Design and strategy for the Cardionome Project, Adv Exp Med Biol, 430, 325, 10.1007/978-1-4615-5959-7_28 · doi:10.1007/978-1-4615-5959-7_28
  6. Popel, 1998, The microcirculation physiome project, Ann Biomed Eng, 26, 911, 10.1114/1.112 · doi:10.1114/1.112
  7. Calonaci, 2012, Optimal vaccination schedule search using genetic algorithm over MPI technology, BMC Med Inform Decis Mak, 12, 129., 10.1186/1472-6947-12-129 · doi:10.1186/1472-6947-12-129
  8. Peleg, 2004, Using Petri Net tools to study properties and dynamics of biological systems, J Am Med Inform Assoc, 12, 181, 10.1197/jamia.M1637 · doi:10.1197/jamia.m1637
  9. Cordero, 2013, Multi-level model for the investigation of oncoantigen-driven vaccination effect, BMC Bioinformatics, 14, S11., 10.1186/1471-2105-14-S6-S11 · doi:10.1186/1471-2105-14-s6-s11
  10. Pennisi, 2016, A methodological approach for using high-level Petri Nets to model the immune system response, BMC Bioinformatics, 17, 498, 10.1186/s12859-016-1361-6 · doi:10.1186/s12859-016-1361-6
  11. Lemon, 2016, The use of mathematical modelling for improving the tissue engineering of organs and stem cell therapy, Curr Stem Cell Res Ther, 11, 666, 10.2174/1574888X10666151001115942 · doi:10.2174/1574888x10666151001115942
  12. Ravvaz, 2017, Personalized anticoagulation: optimizing Warfarin management using genetics and simulated clinical trials, Circ Cardiovasc Genet, 10, e001804, 10.1161/CIRCGENETICS.117.001804 · doi:10.1161/circgenetics.117.001804
  13. Pappalardo, 2015, Computational modelling approaches to vaccinology, Pharmacol Res, 92, 40, 10.1016/j.phrs.2014.08.006 · doi:10.1016/j.phrs.2014.08.006
  14. Viceconti, 2009, Pre-clinical validation of joint prostheses: a systematic approach, J Mech Behav Biomed Mater, 2, 120, 10.1016/j.jmbbm.2008.02.005 · doi:10.1016/j.jmbbm.2008.02.005
  15. Alemani, 2012, Combining cellular automata and Lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition, J Immunol Methods, 376, 55, 10.1016/j.jim.2011.11.009 · doi:10.1016/j.jim.2011.11.009

Cited by

See all 279

Metadata

Authors
Pappalardo, F., Russo, G., Tshinanu, F. M., & Viceconti, M.
Venue
Briefings in Bioinformatics
Published
2018-06-02
Volume
20
Issue
5
Pages
1699-1708
ISSN
  • 1467-5463 (ISSN-L)
  • 1477-4054
OpenAlex
W2806810105
Cited by
279
References
59
FWCI
10.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In silico clinical trials: concepts and early adoptions. https://app.cochat.ai/papers/10.1093/bib/bby043
The paper
Pappalardo, F., Russo, G., Tshinanu, F. M., & Viceconti, M. (2019). In silico clinical trials: concepts and early adoptions. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bby043

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.